论文部分内容阅读
Aim: To investigate the effect of simvastatin on the cardiac contractile function and the alteration of gene and protein expression of the sarcoplasmic calcium regulatory proteins, including sarcoplasmic reticulum Ca~(2+)-ATPase (SERCA), phospholamban (PLB), and ryanodine receptor 2 (RyR2) in rat hearts. Methods: Langendorff-perfused rat hearts were subjected to 60-min perfusion with different concentrations of simvastatin (1,3,10, 30, or 100 μmol/L), and the parameters of cardiac function such as left ventricular developed pressure (LVDP), +dP/dt_(max), and -dp/dt_(max) were determined. The cultured neonatal rat ventricular cardiomyocytes were incubated with simvastatin (1,3,10,30, and 100 μmol/L) for 1 h or 24 h. The levels of SERCA, PLB, and RyR2 expression were measured by reverse tran-scription-polymerase chain reaction and Western blot. Cytotoxic effect of simvastatin on ventricular cardiomyocytes was assessed by the MTT colorimetric assay. Results: LVDP, +dp/dt_(max) and -dp/dt_(max) of hearts were increased significantly after treatment with simvastatin 3, 10, and 30 μmol/L. In simvastatin-treated isolated hearts, the levels of mRNA expression of SERCA and RyR2 were elevated compared with the control (P<0.05), while the mRNA expression of PLB did not change. After the cultured neonatal rat ventricular cardiomyocytes were incubated with 3,10,30, and 100 μmol/L simvastatin for 1 h, SERCA and RyR2 mRNA expressions of cardiomyocytes rose, but there was no alteration in protein expressions. However, with the elongation of simvastatin treatment to 24 h, the protein expression of SERCA and RyR2 were also elevated. Additionally, simvastatin (1-30 μmol/L) had no influence on cell viability of cultured cardiac myocytes, but simvastatin 100 μmol/L inhibited the cell viability. Conclusion: Simvastatin improved cardiac performance accompanied by the elevation of SERCA and RyR2 gene and protein expression.
Aim: To investigate the effect of simvastatin on the cardiac contractile function and the alteration of gene and protein expression of the sarcoplasmic calcium regulatory proteins, including sarcoplasmic reticulum Ca ~ (2 +) - ATPase (SERCA), phospholamban (PLB), and ryanodine Methods: Langendorff-perfused rat hearts were subjected to 60-min perfusion with different concentrations of simvastatin (1, 3, 10, 30, or 100 μmol / L), and the parameters of cardiac function such as left ventricular developed pressure (LVDP), + dP / dt max, and -dp / dt max. were determined. The cultured neonatal rat ventricular cardiomyocytes were incubated with simvastatin (1,3,10,30, and 100 μmol / L) for 1 h or 24 h. The levels of SERCA, PLB, and RyR2 expression were measured by reverse tran-scription-polymerase chain reaction and Western blot. Cytotoxic effect of simvastatin on ventricular cardiomyocytes was assessed by the MTT colorimetric assay Results: LVDP, + dp / dt_ (max) and -dp / d The levels of mRNA expression of SERCA and RyR2 were elevated compared with the control (P <0.05), t_ (max) of hearts were increased significantly after treatment with simvastatin 3, 10, and 30 μmol / L. In simvastatin-treated isolated hearts, , while the mRNA expression of PLB did not change. After the cultured neonatal rat ventricular cardiomyocytes were incubated with 3, 10, 30, and 100 μmol / L simvastatin for 1 h, SERCA and RyR2 mRNA expressions of cardiomyocytes rose, but there was no alteration in protein expressions. However, with the elongation of simvastatin treatment to 24 h, the protein expression of SERCA and RyR2 also also elevated. Additionally, simvastatin (1-30 μmol / L) had no influence on cell viability of cultured cardiac myocytes, but simvastatin 100 μmol / L inhibited the cell viability. Conclusion: Simvastatin improved cardiac performance accompanied by the elevation of SERCA and RyR2 gene and protein expression.